Innovotech Inc (V:IOT) — Market Cap & Net Worth
Market Cap & Net Worth: Innovotech Inc (IOT)
Innovotech Inc (V:IOT) has a market capitalization of $3.15 Million (CA$4.36 Million) as of September 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #29482 globally and #1389 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Innovotech Inc's stock price CA$0.08 by its total outstanding shares 54438232 (54.44 Million). Also see IOT total assets for a full breakdown of the balance sheet.
Innovotech Inc Market Cap History: 2015 to 2026
Innovotech Inc's market capitalization history from 2015 to 2026. Data shows growth from $590.70K to $3.15 Million (16.57% CAGR). Also see Innovotech Inc (IOT) cash flow conversion for how efficiently the company converts equity into cash flow.
Innovotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Innovotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Innovotech Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.34x
Innovotech Inc's market cap is 2.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
112.66x
Innovotech Inc's market cap is 112.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $984.49K | $1.01 Million | -$215.53K | 0.98x | N/A |
| 2017 | $5.71 Million | $990.34K | $753.38K | 5.77x | 7.58x |
| 2018 | $2.36 Million | $826.93K | -$127.63K | 2.86x | N/A |
| 2019 | $4.73 Million | $986.23K | -$48.76K | 4.79x | N/A |
| 2020 | $7.88 Million | $1.19 Million | $106.32K | 6.60x | 74.08x |
| 2021 | $7.48 Million | $1.48 Million | $367.13K | 5.05x | 20.38x |
| 2022 | $5.51 Million | $1.13 Million | -$136.51K | 4.90x | N/A |
| 2023 | $3.15 Million | $1.18 Million | -$157.58K | 2.66x | N/A |
| 2024 | $7.09 Million | $2.19 Million | $224.74K | 3.23x | 31.54x |
| 2025 | $10.63 Million | $4.53 Million | $94.38K | 2.34x | 112.66x |
Competitor Companies of IOT by Market Capitalization
Companies near Innovotech Inc in the global market cap rankings as of September 17, 2026. Review tangible equity quality of Innovotech Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Innovotech Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Innovotech Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Innovotech Inc's market cap moved from $590.70K to $ 3.15 Million, with a yearly change of 16.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$3.15 Million | -70.37% |
| 2025 | CA$10.63 Million | +50.00% |
| 2024 | CA$7.09 Million | +125.00% |
| 2023 | CA$3.15 Million | -42.86% |
| 2022 | CA$5.51 Million | -26.32% |
| 2021 | CA$7.48 Million | -5.00% |
| 2020 | CA$7.88 Million | +66.67% |
| 2019 | CA$4.73 Million | +100.00% |
| 2018 | CA$2.36 Million | -58.62% |
| 2017 | CA$5.71 Million | +480.00% |
| 2016 | CA$984.49K | +66.67% |
| 2015 | CA$590.70K | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Innovotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.15 Million USD |
| MoneyControl | $3.15 Million USD |
| MarketWatch | $3.15 Million USD |
| marketcap.company | $3.15 Million USD |
| Reuters | $3.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more